Clonal evolution driven by superdriver mutations

BMC Evolutionary Biology
Patrick GrossmannNiko Beerenwinkel

Abstract

Tumors are widely recognized to progress through clonal evolution by sequentially acquiring selectively advantageous genetic alterations that significantly contribute to tumorigenesis and thus are termned drivers. Some cancer drivers, such as TP53 point mutation or EGFR copy number gain, provide exceptional fitness gains, which, in time, can be sufficient to trigger the onset of cancer with little or no contribution from additional genetic alterations. These key alterations are called superdrivers. In this study, we employ a Wright-Fisher model to study the interplay between drivers and superdrivers in tumor progression. We demonstrate that the resulting evolutionary dynamics follow global clonal expansions of superdrivers with periodic clonal expansions of drivers. We find that the waiting time to the accumulation of a set of superdrivers and drivers in the tumor cell population can be approximated by the sum of the individual waiting times. Our results suggest that superdriver dynamics dominate over driver dynamics in tumorigenesis. Furthermore, our model allows studying the interplay between superdriver and driver mutations both empirically and theoretically.

References

Oct 1, 1976·Science·P C Nowell
Apr 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·A G Knudson
Nov 5, 2002·Proceedings of the National Academy of Sciences of the United States of America·E Georg Luebeck, Suresh H Moolgavkar
Mar 1, 1953·British Journal of Cancer·C O NORDLING
Mar 1, 1954·British Journal of Cancer·P ARMITAGE, R DOLL
Mar 3, 2004·Nature Reviews. Cancer·Franziska MichorMartin A Nowak
Jun 20, 2006·Genetics·Chris GreenmanDouglas F Easton
Sep 9, 2006·Science·Tobias SjöblomVictor E Velculescu
Jul 20, 2007·Nature Reviews. Genetics·Adam Eyre-Walker, Peter D Keightley
Nov 7, 2007·Proceedings of the National Academy of Sciences of the United States of America·Su-Chan Park, Joachim Krug
Nov 14, 2007·PLoS Computational Biology·Niko BeerenwinkelMartin A Nowak
Sep 30, 2010·Proceedings of the National Academy of Sciences of the United States of America·Ivana BozicMartin A Nowak
Oct 21, 2010·Cancer Prevention Research·Franziska Michor, Kornelia Polyak
Apr 12, 2011·PloS One·Yoh Iwasa, Franziska Michor
Jul 15, 2011·Genome Research·Jamie GuenthoerPeggy L Porter
Nov 10, 2011·PloS One·Moritz GerstungNiko Beerenwinkel
Jun 19, 2012·New Journal of Physics·Erik A MartensOskar Hallatschek
Feb 8, 2013·Proceedings of the National Academy of Sciences of the United States of America·Christopher D McFarlandLeonid A Mirny
Feb 12, 2013·Evolutionary Applications·Ruchira S DattaTrevor A Graham
Feb 12, 2013·Evolutionary Applications·Johannes G ReiterMartin A Nowak
Mar 30, 2013·Science·Bert VogelsteinKenneth W Kinzler
Sep 14, 2013·Blood·Elli PapaemmanuilUNKNOWN Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium
Nov 8, 2013·Journal of Clinical Bioinformatics·Ralf GallaschZlatko Trajanoski
Apr 18, 2014·Nature Reviews. Cancer·Kirill S KorolevJeff Gore
Oct 9, 2014·Systematic Biology·Niko BeerenwinkelFlorian Markowetz
Oct 29, 2014·Proceedings of the National Academy of Sciences of the United States of America·Ivana Bozic, Martin A Nowak
Nov 20, 2014·Nature Communications·Xiaoyue WangKevin P White
Dec 24, 2014·Proceedings of the National Academy of Sciences of the United States of America·Cristian TomasettiBert Vogelstein
Jul 22, 2015·Cancer Discovery·Mel Greaves
Sep 18, 2015·PLoS Computational Biology·Jasmine FooFranziska Michor
Oct 13, 2015·Nature Reviews. Cancer·Francesc Castro-GinerIan Tomlinson
Feb 2, 2016·PLoS Computational Biology·Ivana BozicMartin A Nowak
Feb 6, 2016·PLoS Computational Biology·Niko BeerenwinkelJens Lagergren
Mar 8, 2016·Trends in Cancer·Kamil A LipinskiMarco Gerlinger
May 31, 2016·Cell Reports·Alexandra M PinzaruEros Lazzerini Denchi
Apr 25, 2017·Trends in Cancer·Boyang ZhaoDouglas A Lauffenburger
Oct 24, 2017·Cell·Iñigo MartincorenaPeter J Campbell
Jan 20, 2018·BMC Cancer·Karen GomezSudhir Kumar
Apr 4, 2018·Nature Genetics·Zoë N RogersMonte M Winslow
Jun 14, 2018·Proceedings of the National Academy of Sciences of the United States of America·Jaime IranzoEugene V Koonin
Oct 20, 2018·Science·Iñigo MartincorenaPhilip H Jones
Oct 27, 2018·Journal of the National Cancer Institute·Vincent L CannataroJeffrey P Townsend

❮ Previous
Next ❯

Software Mentioned

GCC
Linux
sim Mult
R

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

BioRxiv : the Preprint Server for Biology
Yeuk P. G. PoonJamie R. Blundell
Frontiers in Physiology
Beatriz Stransky, Sandro J de Souza
© 2021 Meta ULC. All rights reserved